From: Systematic review of case reports on COVID-19 associated myocarditis: a discussion on treatments
Diagnostic testing | Total | % (number of cases/total cases) |
---|---|---|
Echocardiogram results | ||
Reduced left ventricular ejection fraction (LVEF) | 95 | 68 |
Pericardial effusion | 35 | 25 |
Ventricular Hypertrophy | 17 | 12 |
Valve Regurgitation | 13 | 9 |
Dilated cardiomyopathy | 8 | 6 |
Hypokinesia | 56 | 40 |
Thrombus | 9 | 6 |
Normal | 19 | 14 |
Use of Cardiac MRI | 59 | 40 |
Use of Coronary angiography | 28 | 19 |
Use of Endomyocardial Biopsy | 18 | 12 |
EKG Findings | ||
ST elevation | 31 | 24 |
ST elevation; diffuse | 19 | 15 |
ST depression | 11 | 9 |
T-wave inversion | 23 | 18 |
Sinus tachycardia | 37 | 29 |
Normal | 13 | 10 |
Elevated lab values | ||
Troponin | 128 | 90 |
D-dimer | 57 | 40 |
Pro B-type natriuretic peptide | 65 | 46 |
C-reactive Protein | 83 | 59 |
Normal | 4 | 3 |